Form D — Blue Marlin Therapeutics, Inc.
0002092364-25-000001 · filed Oct 21, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- —
- Total sold
- $100,000
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Blue Marlin Therapeutics, Inc.
- CIK
- 2092364
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 200 GARRETT STREET
CHARLOTTESVILLE, VA 22902 - Phone
- 434-980-8104
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sean Stalfort · Executive OfficerCharlottesville, VA Find on LinkedIn ↗
-
Paul Manning · Executive OfficerCharlottesville, VA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗